The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

ORforglipron is a Experimental drug a small (non-peptide) oral agonist of the GLP-1 receptor oral, which does not require ...

Leveraging AI, researchers have identified a naturally occurring molecule that can suppress appetite and facilitate weight loss in mice and pigs.

GLP-1 use significantly lowered risk for atrial fibrillation-related events for patients with diabetes, AF and obesity, with ...

It’s common to feel nervous (and maybe even spaced out) when your doctor demonstrates how to inject yourself with ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

SGLT2 inhibitors, compared with GLP1 agonists, significantly lower risk for atrial fibrillation in patients with type 2 diabetes.

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Fibersol®, a digestion-resistant soluble dietary fiber backed by over 30 years of extensive clinical research, may support ...

All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...

The weight-loss drugs have grown in popularity, but are generally too expensive for most people to afford without insurance ...